Pre-made Tamrintamab benchmark antibody ( Whole mAb ADC, anti-DPEP3 therapeutic antibody, Anti-MBD3 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Tamrintamab biosimilar, Whole mAb ADC, Anti-DPEP3 Antibody: Anti-MBD3 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Tamrintamab pamozirine, also known as SC-003, is an ADC composed of a proprietary antibody against DPEP3 (dipeptidase 3) also known as MBD3, a glycosylphosphatidylinositol anchored membrane protein from the DPEP family of dipeptidase proteins.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-547-1mg	1mg	Inquiry
GMP-Bios-ab-547-10mg	10mg	Inquiry
GMP-Bios-ab-547-100mg	100mg	Inquiry
GMP-Bios-ab-547-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Tamrintamab biosimilar, Whole mAb ADC, Anti-DPEP3 Antibody: Anti-MBD3 therapeutic antibody
INN Name	Tamrintamab
Target	DPEP3
Format	Whole mAb ADC
Derivation	Humanized
Species Reactivity	Human
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-I
Est. Status	Active
100% SI Structure	6vgr:HL:CD
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2018
Year Recommended	2019
Companies	Stemcentrx
Conditions Approved	na
Conditions Active	Ovarian cancer;Solid tumours
Conditions Discontinued	na
Development Tech	na